Open access
Aug 2026
Tea and liver fibrosis: a bibliometric analysis of mechanisms, translational challenges, and emerging trends
With advances in nanomedicine and pharmaceutical technologies, coupled with rigorously designed multicenter randomized controlled trials, tea-derived bioactives are anticipated to overcome current limitations and establish clinical value in liver fibrosis prevention and adjuvant therapy.
Fei Yu, Si-Han Yin, Jia-Yu Zhu et al.
· Frontiers in Nutrition · 0 citations